Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

17

Revenue 2014

Novo Nordisk

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.

ALK-Abello appoints Søren Jelert as CFO

ALK-Abello appoints Søren Jelert as CFO

His career has seen him serve in various capacities for Novo Nordisk, including as finance director Europe North and manager operations, finance. ... Carsten Hellmann, president and chief executive officer, ALK, said: “Søren brings a wealth of

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity Novo Nordisk gets FDA nod for once-weekly rival to Lilly’ s Trulicity. ... The US FDA has approved Novo Nordisk’s once-weekly GLP-1 agonist Ozempic for type 2 diabetes, setting up a marketing clash with Eli Lilly’s fast-growing Trulicity rival.

STEM Healthcare bolsters its EU5 team

STEM Healthcare bolsters its EU5 team Alongside Troman, Adam Boucher (pictured left) joins STEM as a project director following 17 years’experience within UK and international healthcare roles for Bristol-Myers Squibb and Novo Nordisk.

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra Novo Nordisk is developing a once-weekly version of its established NovoEight product - called N8-GP - that could be filed next year.

Roche gets first approval for haemophilia A therapy

Roche gets first approval for haemophilia A therapy The market for haemophilia A with inhibitors is currently dominated by Shire and Novo Nordisk with their Feiba and NovoSeven bypassing agents (PBAs).

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...

Infographics